Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5 Suppl 2
|
pubmed:dateCreated |
1993-6-11
|
pubmed:abstractText |
In this paper we report some results of our studies on patients with immunoglobulin (Ig)A nephropathy regarding (1) the familiar aggregation of erythrocyte sodium-lithium (Na,Li) countertransport; (2) the association of Na,Li countertransport with the presence of arterial hypertension and lipid abnormalities; (3) the correlation between Na,Li countertransport activity and renal functional reserve; and (4) the preliminary results of a longitudinal study. In 13 families of patients with IgA nephropathy, selected because both parents were available, we found a significant correlation between midparent and offspring Na,Li countertransport activity (Spearman's rank correlation = 0.65; P = 0.023), but no husband-wife relationship. In 49 patients, the activity of Na,Li countertransport was significantly higher in erythrocytes from 20 hypertensive patients than from either 29 normotensive patients or from 36 healthy age- and sex-matched normal subjects. Hyperlipidemic patients had an erythrocyte Na,Li countertransport activity significantly higher than normolipidemic patients and controls. In 17 patients a significant inverse correlation was found between the peak variation of creatinine clearance over baseline value after an oral protein load and the erythrocyte Na,Li countertransport activity (Spearman r = 0.54; P = 0.03). In a longitudinal study of 36 patients followed from 12 to 36 months, those showing a progression toward renal failure had an erythrocyte Na,Li countertransport activity higher than median value. The results of our studies show that in patients with IgA nephropathy a high erythrocyte Na,Li countertransport rate, genetically determined, is associated with the presence of arterial hypertension and lipid abnormalities, and perhaps with a less favorable disease outcome.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0272-6386
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
61-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8494021-Adolescent,
pubmed-meshheading:8494021-Adult,
pubmed-meshheading:8494021-Biological Transport, Active,
pubmed-meshheading:8494021-Erythrocytes,
pubmed-meshheading:8494021-Female,
pubmed-meshheading:8494021-Glomerulonephritis, IGA,
pubmed-meshheading:8494021-Humans,
pubmed-meshheading:8494021-Hypertension,
pubmed-meshheading:8494021-Lipids,
pubmed-meshheading:8494021-Lithium,
pubmed-meshheading:8494021-Male,
pubmed-meshheading:8494021-Middle Aged,
pubmed-meshheading:8494021-Prospective Studies,
pubmed-meshheading:8494021-Sodium
|
pubmed:year |
1993
|
pubmed:articleTitle |
Sodium-lithium countertransport activity in red blood cells of patients with IgA nephropathy.
|
pubmed:affiliation |
Istituto di Nefro-Urologia dell'Università, Ospedale G. Bosco, Torino, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|